Not negative at all, sorry. You must understand that the 12-week data was only for the ADCS-ADL, and not the MMSE or any other of the test batteries. That raises concerns of "cherry picking". Folks are blaming conspiracies and all kinds of boogymen for why ANVX is volatile when there's plenty of reasons right in front of us. Biotech is risky and info is gold.
Looking forward to the 12-weeks results and some word from the company on whether another extensions was done or not.
Market Data 
Markets 
AI
